Development and validation of the NEOS2 score for prediction of long-term outcomes and improvement after first-line immunotherapy in patients with anti-NMDAR encephalitis: an international cohort studyResearch in context
Summary: Background: Anti-N-methyl-d-aspartate receptor (anti-NMDAR) encephalitis is a severe disease that primarily affects young people and can improve with adequate treatment. We aimed to refine the anti-NMDAR Encephalitis One-year functional Status (NEOS) score by developing NEOS2, an updated m...
保存先:
| 主要な著者: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier
2026-03-01
|
| シリーズ: | The Lancet Regional Health. Europe |
| 主題: | |
| オンライン・アクセス: | http://www.sciencedirect.com/science/article/pii/S2666776225003540 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|
